JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 23, 2004; DOI: 10.1124/jpet.103.062950


0022-3565/04/3092-540-547$20.00
JPET 309:540-547, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.062950v1
309/2/540    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carter, L. P.
Right arrow Articles by France, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, L. P.
Right arrow Articles by France, C. P.

BEHAVIORAL PHARMACOLOGY

The Discriminative Stimulus Effects of {gamma}-Hydroxybutyrate and Related Compounds in Rats Discriminating Baclofen or Diazepam: The Role of GABAB and GABAA Receptors

L. P. Carter, A. W. Unzeitig, H. Wu, W. Chen, A. Coop, W. Koek, and C. P. France

Department of Pharmacology (L.P.C., A.W.U., W.K., C.P.F.) and Psychiatry (W.K., C.P.F.), The University of Texas Health Science Center at San Antonio, San Antonio, Texas; and Department of Pharmaceutical Sciences (H.W., W.C., A.C.), University of Maryland, Baltimore, Maryland

The discriminative stimulus effects of {gamma}-hydroxybutyrate (GHB) can be mimicked by GABAA receptor-positive modulators (e.g., diazepam) and GABAB receptor agonists (e.g., baclofen). The purposes of this study were to see whether stimulus control could be established with baclofen and to further characterize the role of GABAergic mechanisms in the behavioral actions of GHB by evaluating GHB and related compounds in rats discriminating either diazepam or baclofen. Training criteria were satisfied with baclofen and diazepam after 69 and 44 sessions, respectively. GHB and its precursors {gamma}-butyrolactone and 1,4-butanediol occasioned >80% responding on the drug-associated lever in rats discriminating baclofen and <11% in rats discriminating diazepam. Diazepam and other GABAA receptor-positive modulators occasioned intermediate levels of responding on the baclofen lever, whereas baclofen occasioned less than 4% responding on the diazepam lever. The GABAB receptor antagonist CGP 35348 [(3-aminopropyl)(diethoxymethyl) phosphinic acid] partially antagonized the effects of baclofen as well as the baclofen-like effects of GHB, and flumazenil partially antagonized the effects of diazepam. This study established stimulus control with baclofen, and substitution data provided direct evidence for a role of GABAergic, especially GABAB, mechanisms in the discriminative stimulus effects of GHB. The lack of substitution by GHB or its metabolic precursors for diazepam indicates a comparatively smaller role of GABAA mechanisms in these effects of GHB. The inability of CGP 35348 to completely attenuate the effects of baclofen and GHB suggests that multiple receptors could be involved in the discriminative stimulus effects of GHB.


Received November 12, 2003; accepted January 22, 2004.

Address correspondence to: Dr. Charles P. France, Department of Pharmacology, Mail Code 7764, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900. E-mail: france{at}uthscsa.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
W. Koek, L. P. Carter, R. J. Lamb, W. Chen, H. Wu, A. Coop, and C. P. France
Discriminative Stimulus Effects of {gamma}-Hydroxybutyrate (GHB) in Rats Discriminating GHB from Baclofen and Diazepam
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 170 - 179.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. P. Carter, H. Wu, W. Chen, M. M. Matthews, A. K. Mehta, R. J. Hernandez, J. A. Thomson, M. K. Ticku, A. Coop, W. Koek, et al.
Novel {gamma}-Hydroxybutyric Acid (GHB) Analogs Share Some, but Not All, of the Behavioral Effects of GHB and GABAB Receptor Agonists
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1314 - 1323.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.